文献速递甲状腺疾病

甲状腺乳头状癌中特异性长链非编码RNA表达谱的鉴定及其与临床病理特征和BRAF突变关联的分析

Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
PubMed 文献 · Thyroid · 2016-10-31

本研究采用RNA测序和定量逆转录聚合酶链反应检测12对甲状腺乳头状癌(PTC)与配对正常邻近组织的转录组差异,发现188个lncRNA和505个mRNA差异表达,并在31对标本中验证47个lncRNA和39个mRNA。NONHSAT076747和NONHSAT122730与淋巴结转移相关,NONHSAG051968表达与肿瘤大小负相关,并揭示了BRAF突变分层的转录组亚型模式。

要点

  • PTC组织与配对正常组织间存在188个lncRNA和505个mRNA差异表达。
  • NONHSAT076747和NONHSAT122730与淋巴结转移相关。
  • NONHSAG051968表达与肿瘤大小负相关,BRAF突变相关基因中p53信号通路富集最显著。

核心结论

  • 本研究揭示了PTC相关的特异性lncRNA表达谱改变,PTC相关lncRNA NONHSAG051968、NONHSAT076747和NONHSAT122730可能是PTC患者的潜在诊断和治疗靶点,按BRAF突变分层的亚型特异性lncRNA可能在个体分子亚型中具有重要意义。

研究设计与样本

  • 研究采用RNA测序和定量逆转录聚合酶链反应检测12对PTC组织与配对正常邻近组织的转录组变化,并在31对PTC标本中验证差异表达的lncRNA和mRNA。
  • 分析差异表达lncRNA与临床病理特征的统计相关性,通过共表达mRNA注释预测lncRNA功能,并分析BRAF突变重塑的PTC转录组特定亚型模式。

主要发现

  • RNA测序显示,在50%或以上的PTC组织中,共有188个lncRNA和505个mRNA差异表达(倍数变化>2;p<0.05)。
  • 在31对PTC标本中验证了47个lncRNA和39个mRNA,结果与RNA测序数据一致。
  • NONHSAT076747和NONHSAT122730与淋巴结转移相关,NONHSAG051968表达与肿瘤大小负相关。
  • 功能分析提示差异表达基因主要参与ECM-受体相互作用和黏着斑通路。
  • BRAF突变相关基因中p53信号通路是富集程度最高的通路。

关键数值与推荐

  • 差异表达标准为在50%或以上的PTC组织中倍数变化>2且p<0.05。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In recent years, long non-coding RNAs (lncRNAs) have been shown to play a critical regulatory role in cancer biology. However, the contribution of lncRNAs to papillary thyroid cancer (PTC) remains largely unknown. METHODS: RNA sequencing and quantitative reverse transcription polymerase chain reaction were used to detect and verify changes to the transcriptome profile in 12 PTC tissues compared to paired normal adjacent tissues. The statistical correlation between differentially expressed lncRNAs and clinicopathologic characteristics was analyzed, and potential lncRNA functions were predicted by examining annotations for the co-expressed mRNAs. Furthermore, the specific subgroup patterns of the PTC transcriptome remodeled by BRAF mutations were also analyzed. RESULTS: A total of 188 lncRNAs and 505 mRNAs were differentially expressed in 50% or more of the PTC tissues (fold change >2; p < 0.05) as assessed by RNA-sequencing compared with paired normal adjacent tissues. Forty-seven lncRNAs and 39 mRNAs were verified in 31 pairs of PTC specimens using quantitative reverse transcription polymerase chain reaction, and the results were consistent with the RNA sequencing data. The lncRNAs NONHSAT076747 and NONHSAT122730 were associated with lymph node metastasis, and NONHSAG051968 expression was negatively correlated with tumor size. A co-expression network between differentially expressed lncRNAs and protein-coding RNAs was constructed and analyzed, and functional analysis suggested that the differentially expressed genes mainly participate in ECM-receptor interactions and the focal adhesion pathway. Furthermore, a specific PTC transcriptome subtype pattern stratified by BRAF mutation was also uncovered. The p53 signaling pathway was the most highly enriched pathway among the BRAF mutation-related genes. CONCLUSIONS: This study reveals specific changes to the lncRNA profile associated with PTC, and provides new insight into its pathogenesis. The PTC-associated lncRNAs NONHSAG051968, NONHSAT076747, and NONHSAT122730 might be potential diagnostic and therapeutic targets for PTC patients, and lncRNAs with subtype-specific expression stratified by BRAF mutation might be significant in individual molecular subtypes.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Wang Q, Yang H, Wu L, et al. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer. Thyroid. 2016. PMID: 27758138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。